Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?

BACKGROUND:Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) ≥4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold...

Full description

Bibliographic Details
Main Authors: Ofir Koren, Arin Nasser, Mazen Elias, Gilat Avraham, Nahum Freidberg, Walid Saliba, Lee H Goldstein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235683
id doaj-80758ece5ae34464b8eebe63fa098dce
record_format Article
spelling doaj-80758ece5ae34464b8eebe63fa098dce2021-03-03T21:54:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023568310.1371/journal.pone.0235683Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?Ofir KorenArin NasserMazen EliasGilat AvrahamNahum FreidbergWalid SalibaLee H GoldsteinBACKGROUND:Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) ≥4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. METHOD:In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. RESULTS:568 high risk patients (PPS ≥4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. CONCLUSIONS:The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS ≥4, the risk of VTE may differ dramatically between populations.https://doi.org/10.1371/journal.pone.0235683
collection DOAJ
language English
format Article
sources DOAJ
author Ofir Koren
Arin Nasser
Mazen Elias
Gilat Avraham
Nahum Freidberg
Walid Saliba
Lee H Goldstein
spellingShingle Ofir Koren
Arin Nasser
Mazen Elias
Gilat Avraham
Nahum Freidberg
Walid Saliba
Lee H Goldstein
Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
PLoS ONE
author_facet Ofir Koren
Arin Nasser
Mazen Elias
Gilat Avraham
Nahum Freidberg
Walid Saliba
Lee H Goldstein
author_sort Ofir Koren
title Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
title_short Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
title_full Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
title_fullStr Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
title_full_unstemmed Low venous thromboembolism incidence in high risk medical patients in an Israeli hospital. Can risk assessment be extrapolated to different populations?
title_sort low venous thromboembolism incidence in high risk medical patients in an israeli hospital. can risk assessment be extrapolated to different populations?
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description BACKGROUND:Guidelines recommend venous thromboembolism (VTE) prophylaxis in hospitalized medical patients with Padua prediction score (PPS) ≥4 points. This recommendation is based on the high risk of symptomatic VTE observed among these patients in the Italian PPS derivation study, and the fivefold risk reduction with VTE-prophylaxis. This study aims to assess the incidence of VTE in high risk medical patients in a medium sized hospital in Israel. METHOD:In this retrospective cohort study, data was collected of all medical patients hospitalized between January and June 2014. Patients were classified into low and high risk groups according to their PPS score, and according to whether they received anticoagulant thromboprophylaxis for VTE. Patients were further randomly selected to compare high risk patients that did or did not receive anticoagulant thromboprophylaxis. We further compared VTE incidence in high and low risk patients not treated with thromboprophylaxis. A search was conducted for diagnoses of venous thromboembolism and death during hospitalization and the following 90 days. RESULTS:568 high risk patients (PPS ≥4 points) were included, 284 treated with prophylactic anticoagulation and 284 not. There were no VTE events in either group. There was no difference in mortality. A total of 642 non anticoagulated patients were randomly selected, 474 low risk and 168 high risk. There were no VTE events in either group. CONCLUSIONS:The risk of VTE appears to be very low in our study, suggesting that among medical patients with PPS ≥4, the risk of VTE may differ dramatically between populations.
url https://doi.org/10.1371/journal.pone.0235683
work_keys_str_mv AT ofirkoren lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT arinnasser lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT mazenelias lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT gilatavraham lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT nahumfreidberg lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT walidsaliba lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
AT leehgoldstein lowvenousthromboembolismincidenceinhighriskmedicalpatientsinanisraelihospitalcanriskassessmentbeextrapolatedtodifferentpopulations
_version_ 1714814444435931136